Bio-Rad Labs Inc. A buy Wells Fargo & Company
Start price
07.08.23
/
50%
€364.80
Target price
07.08.24
€477.33
Performance (%)
-20.83%
End price
08.08.24
€288.80
Summary
This prediction ended on 08.08.24 with a price of €288.80. The prediction for Bio-Rad Labs Inc. A disappointed with a performance of -20.83%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | -5.618% | -5.618% | -26.423% |
| iShares Core DAX® | 1.130% | 2.184% | 15.737% |
| iShares Nasdaq 100 | 1.128% | -0.611% | 7.324% |
| iShares Nikkei 225® | 2.610% | 4.958% | 20.446% |
| iShares S&P 500 | -0.006% | -0.952% | 2.166% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Wells Fargo & Company from $550.00 to $525.00. They now have an "overweight" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€355.00
16.06.23
16.06.23
€502.10
16.06.24
16.06.24
-25.32%
17.06.24
17.06.24
